George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Assume the AGM is still on since there has been no comms to say it isn't? Is anyone in attendance?
Well, not sure about NASDAQ other than it’s not trading their either.
Removal from Russell index is just admin. Not trading so can’t list it. Not anything we don’t already know. Unsure about NASDAQ.
Despite that incredible Oncology RNS they didn’t raise at 70p… instead they continue with the punitive OF funding. Something isn’t right here.
Wasn’t so long ago that 4D’s oncology results RNS was stated by many to be one of the best RNS’s ever seen on AIM. Three months later….. : ( Unbelievable.
Kicked off index. Expected.
Not back in the country fur a couple of weeks but highly likely to raise a case myself when I am, unless things change dramatically in the meantime (which I do not expect). Multiple emails to IR ignored in recent weeks. Shareholder neglect wouldn’t be hard to prove.
Should get an RNS today to say that the AGM is cancelled, no? Or it it still happening?
Agree BB. Something not right here, or this was planned. Either way, shareholders have been stitched up.
Agree @fairdealer. If financing was this tight then they had opportunity to raise at just over 70p not too long ago on the oncology results. Why didn't they? Either this situation has been planned (wouldn't be surprised given the dire state of IR) or they were expecting news or funding of some kind that hasn't come. Are they really this incompetent to simply risk the whole company on a punitive deal with OF? That just doesn't make sense to me.
4d Pharma PLC - Leeds, England-based pharmaceutical company - Says it has ‘no immediate certainty’ of how it will repay the $13.9 million loan facility it has with Oxford Finance LLC. ‘The board has been exploring opportunities to secure additional funding for the company in recent months, however this has proved challenging but 'significant progress' had been made, despite the very difficult prevailing market conditions,’ it says.
I'm sure we would all be interested to hear what this 'significant progress' is exactly.
No 'immediate certainty' may also not mean there is nothing confirmed as yet but that it could be. It could also mean there are no real options. Lets hope for the former.
Yes, feel for them all. Awful situation.
The only real potential hope I see here (and its incredibly slim of course) is that Merck or another big pharma don't want to see all of this research and progress vanish and so simply take 4D under their wing. Could fall apart very quickly as research scientists and others will no doubt begin to look for alternative employment and Merck, or another, may want to stop that. If the results are proving as positive as 4D has suggested then it makes sense for a quick and cheap buyout to happen. The amount of money involved (particularly given the accounting benefits to a profitable company detailed by @biffa) is incredibly small to those such as Merck. Pound is also weak against $ currently which may also benefit a UK company sale. Under no illusions here and not wanting to give any false hope. If every piece of luck was on our side its possible that 4D could benefit in the long term from not being under the punitive deal offered by OF. Best to assume the money is gone however and simply hope that a miracle does happen here.
Well, got to assume out our money is gone currently Gogs so not sure things can get worse....
Merck is profitable.
Oh I know, don't worry. Merck won't do 4D any favours if its not in their interest. How much did they buy in at for that original 5%, was it 110p? (I've no idea) Could perhaps get the whole company for that same amount of money again. Its crazy.
Definitely was something fishy going on with those Algo's on both exchanges. Had it not been shorted so intensely then raise at a much higher price may have been a possibility. Perhaps something more pre-mediated by an interested party. Who knows. We never will know that and its pointless speculating now. We are where we are. The only glimmer of hope I have is that if 4D and Merck were best buddies as DP alluded to then they may want to buy this up quick. What a deal to support Keytruda and other areas of their research. Not likely I know but its a tiny glimmer.
Surely, for the price it is now or something close to it, some big pharma would be keen. Unbelievable bargain out of the admin bin with the BoD over a barrel. Pick it up before its broken up. Again, in my mind my money is already gone so certainly no false hope but Merck or another would have to be interested I would have thought.
Well that's a small positive potentially. Doesn't mean that PI's will get a slice of any pie but perhaps shows a bit of fight at least.
Did wonder why Duncan just threw in that last minute comment about Micro RX being better and worth more than another Pharma's product that sold at over a $Billion. Think he perhaps knew the game was up at that point and wanted to point that out pre-admin. Think someone would get it a bit cheaper now.
He might not care about other investors but if 4D want to become a big player in the pharma market (if indeed its salvageable) he will need to think about his reputation and that of his company, both in the UK and in the US. Hopefully that will play some part. Now that he's tied up with Merck and others its not a good look to play the Aim game and simply spin off another company. I'm probably being too naïve but lets hope not.